MRKR / Marker Therapeutics, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Marker Therapeutics, Inc.
US ˙ NasdaqCM ˙ US57055L2060

Deler fremragende 16,673,127 shares
Insideraktier11.739.199 shares
Insider ejerskab70,41 %
Total Insiders39
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
4922 out of 10986

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
5246 out of 10856

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Marker Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Nadia Agopyan 40.000
Peter J Barris 10% Owner - [10%] 10.000.000 1.000.000
Forest Baskett 10% Owner - [10%] 10.714.285 1.625.678
John N Bonfiglio President and COO, Director - [D] [O] 26.054 26.054
Ali Behbahani 10% Owner - [10%] 10.714.285 1.625.678
Denis Corin President, Director - [D] [O] 2.394.535 2.394.535
Carmen Chang 10% Owner - [10%] 10.714.285 1.625.678
Steve Elms Director - [D] 328.338 328.338
Norman David Eansor Director - [D] 7.142 7.142
Capital LTD Eastern 10% Owner - [10%] 4.050.001 405.000
Florence Anthony A. Jr. 10% Owner - [10%] 10.714.285 1.625.678
Gerald Garrett 40.000
Sherry Grisewood Director - [D] 19.582 19.582
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Hoang Peter L. President and CEO, Director - [D] [O] 483.286 48.329
Tsvetelina P Hoang VP, Research and Development - [O] 359.422 35.942
Kim Anthony H. Chief Financial Officer - [O] 114.436 11.444
Katharine Knobil Director - [D] 1.500 150
Mythili Koneru 160.000
David Laskow-Pooley Director - [D] 55.223 5.522
Leen Ann M. Chief Scientific Officer - [O] 3.986.118 398.612
Michael Loiacono 140.000
Joshua Makower 10% Owner - [10%] 10.714.285 1.071.428
David M Mott 10% Owner - [10%] 10.000.000 1.000.000
Mohamad Makhzoumi 10% Owner - [10%] 10.714.285 1.625.678
Ken Moseley 0
Nea 16 Gp, Llc 10% Owner - [10%] 10.714.285 1.625.678
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
NEA Partners 16, L.P. 10% Owner - [10%] 10.714.285 1.625.678
New Enterprise Associates 16, L.P. 10% Owner - [10%] 1.625.678 1.625.678
Mark Reddish Director - [D] 36.110 36.110
Scott D Sandell 10% Owner - [10%] 10.714.285 1.625.678
Joshua Silverman Director - [D] 17.221 17.221
Sonsini Peter W. 10% Owner - [10%] 10.714.285 1.071.428
Anna Szymanska 40.000
Juan Vera Chief Scientific Officer & COO, Director - [D] [O] 2.671.845 267.184
Ravi Viswanathan 10% Owner - [10%] 10.000.000 1.000.000
Glynn Wilson Director - [D] 181.776 181.776
Paul Edward Walker 10% Owner - [10%] 10.714.285 1.625.678
Frederick Gerald Wasserman Director - [D] 65.223 6.522
John Robert Wilson Director - [D] 7.812.008 781.201

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i MRKR / Marker Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-12-23 New Enterprise Associates 16, L.P. 554.250 3,2000 554.250 3,2000 1.773.600 4 3.4900 160.732 9,06
2024-12-23 ELMS STEVE 11.085 3,2000 11.085 3,2000 35.472
2021-05-18 Wasserman Frederick Gerald 10.000 2,4098 1.000 24,0980 24.098
2021-03-16 Hoang Peter L. 142.857 1,7500 14.286 17,5000 250.000
2021-03-16 Wilson John Robert 1.714.285 1,7500 171.428 17,5000 2.999.999
2021-03-16 ELMS STEVE 1.142.857 1,7500 114.286 17,5000 2.000.000
2021-03-16 Vera Juan 571.428 1,7500 57.143 17,5000 999.999
2021-03-16 New Enterprise Associates 16, L.P. 5.714.285 1,7500 571.428 17,5000 9.999.999
2021-03-16 Eansor Norman David 14.285 17,5000 1.428 175,0000 249.988

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MRKR / Marker Therapeutics, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i MRKR / Marker Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MRKR / Marker Therapeutics, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2024-12-26 2024-12-23 4 ELMS STEVE MRKR Common Stock P - Purchase I 3,2000 11.085 35 325.370
2024-12-23 2024-12-23 4 New Enterprise Associates 16, L.P. MRKR Common Stock P - Purchase D 3,2000 554.250 1.774 1.625.678
2023-06-08 2021-03-25 4 Eansor Norman David By the John R. Eansor 2020 Exempt Trust MRKR Common Stock G - Gift I 7.142 7.142
2023-06-08 2021-03-25 4 Eansor Norman David By the Scott Eansor 2020 Exempt Trust MRKR Common Stock G - Gift I 7.142 7.142
2023-06-08 2021-03-25 4 Eansor Norman David MRKR Common Stock G - Gift D -14.285 2.428
2023-06-08 2021-03-16 4 Eansor Norman David MRKR Common Stock P - Purchase D 17,5000 14.285 250 16.713
2022-05-26 2022-05-24 4 ELMS STEVE MRKR Stock Option (Right to Buy) A - Award D 0,34 80.000 80.000
2022-05-26 2022-05-24 4 Laskow-Pooley David MRKR Stock Option (Right to Buy) A - Award D 0,34 80.000 80.000
2022-05-26 2022-05-24 4 Wilson John Robert MRKR Stock Option (Right to Buy) A - Award D 0,34 80.000 80.000
2022-05-26 2022-05-24 4 Eansor Norman David MRKR Stock Option (Right to Buy) A - Award D 0,34 80.000 80.000
2022-05-26 2022-05-24 4 Knobil Katharine MRKR Stock Option (Right to Buy) A - Award D 0,34 80.000 80.000
2022-03-28 2022-03-24 4 Hoang Peter L. MRKR Common Stock F - Taxes D 0,4848 -48.376 -23 483.286
2022-03-28 2022-03-24 4 Hoang Peter L. MRKR Common Stock A - Award D 199.094 531.662
2022-03-28 2022-03-24 4 Vera Juan MRKR Common Stock F - Taxes D 0,4848 -33.465 -16 2.671.845
2022-03-28 2022-03-24 4 Vera Juan MRKR Common Stock A - Award D 140.823 2.705.310
2022-03-28 2022-03-24 4 Kim Anthony H. MRKR Common Stock F - Taxes D 0,4848 -36.076 -17 114.436
2022-03-28 2022-03-24 4 Kim Anthony H. MRKR Common Stock A - Award D 150.512 150.512
2022-02-22 2022-02-17 4 Hoang Peter L. MRKR Employee Stock Option (right to buy) A - Award D 0,46 430.000 430.000
2022-02-22 2022-02-17 4 Szymanska Anna MRKR Employee Stock Option (right to buy) A - Award D 0,46 40.000 40.000
2022-02-22 2022-02-17 4 Vera Juan MRKR Employee Stock Option (right to buy) A - Award D 0,46 160.000 160.000
2022-02-22 2022-02-17 4 Koneru Mythili MRKR Employee Stock Option (right to buy) A - Award D 0,46 160.000 160.000
2022-02-22 2022-02-17 4 Loiacono Michael MRKR Employee Stock Option (right to buy) A - Award D 0,46 140.000 140.000
2022-02-22 2022-02-17 4 Kim Anthony H. MRKR Employee Stock Option (right to buy) A - Award D 0,46 160.000 160.000
2022-02-22 2022-02-17 4 Hoang Tsvetelina P MRKR Employee Stock Option (right to buy) A - Award D 0,46 40.000 40.000
2022-02-22 2022-02-17 4 Agopyan Nadia MRKR Employee Stock Option (right to buy) A - Award D 0,46 40.000 40.000
2022-02-22 2022-02-17 4 Garrett Gerald MRKR Employee Stock Option (right to buy) A - Award D 0,46 40.000 40.000
2021-12-09 2021-12-08 4 Knobil Katharine MRKR Stock Option (Right to Buy) A - Award D 1,20 125.000 125.000
2021-12-09 3 Knobil Katharine MRKR Common Stock I 1.500
2021-06-10 2021-06-08 4 Wasserman Frederick Gerald MRKR Common Stock A - Award D 12.658 65.223
2021-06-10 2021-06-08 4 Laskow-Pooley David MRKR Common Stock A - Award D 12.658 55.223
2021-06-10 2021-06-08 4 ELMS STEVE MRKR Common Stock A - Award D 12.658 29.680
2021-06-10 2021-06-08 4 Wilson John Robert MRKR Common Stock A - Award D 12.658 7.812.008
2021-06-10 2021-06-08 4 Eansor Norman David MRKR Common Stock A - Award D 12.658 36.940
2021-05-20 2021-05-18 4 Wasserman Frederick Gerald MRKR Common Stock P - Purchase D 2,4098 10.000 24 52.565
2021-03-18 2021-03-16 4 New Enterprise Associates 16, L.P. MRKR Common Stock P - Purchase D 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 BASKETT FOREST See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Behbahani Ali See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Chang Carmen See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Florence Anthony A. Jr. See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Makhzoumi Mohamad See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 MAKOWER JOSHUA See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Sonsini Peter W. See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Walker Paul Edward See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 SANDELL SCOTT D See Note 1 MRKR Common Stock P - Purchase I 1,7500 5.714.285 10.000 10.714.285
2021-03-18 2021-03-16 4 Wilson John Robert MRKR Common Stock P - Purchase D 1,7500 1.714.285 3.000 7.799.350
2021-03-18 2021-03-16 4 Vera Juan MRKR Common Stock P - Purchase D 1,7500 571.428 1.000 2.564.487
2021-03-18 2021-03-16 4 Hoang Peter L. MRKR Common Stock P - Purchase D 1,7500 142.857 250 332.568
2021-03-18 2021-03-16 4 ELMS STEVE MRKR Common Stock P - Purchase I 1,7500 1.142.857 2.000 3.142.857
2021-02-12 2020-05-19 5 Eansor Norman David MRKR Common Stock A - Award D 17.022 24.282
2021-02-12 2020-05-19 5 ELMS STEVE MRKR Common Stock A - Award D 17.022 17.022
2021-02-12 2020-05-19 5 Laskow-Pooley David MRKR Common Stock A - Award D 17.022 42.565
2021-02-12 2020-05-19 5 Wasserman Frederick Gerald MRKR Common Stock A - Award D 17.022 42.565
2021-02-12 2020-05-19 5 Wilson John Robert MRKR Common Stock A - Award D 17.022 6.085.065
2021-02-12 2021-02-10 4 Vera Juan MRKR Employee Stock Option (right to buy) A - Award D 3,29 140.000 140.000
2021-02-12 2021-02-10 4 Szymanska Anna MRKR Employee Stock Option (right to buy) A - Award D 3,29 40.000 40.000
2021-02-12 2021-02-10 4 Loiacono Michael MRKR Employee Stock Option (right to buy) A - Award D 3,29 140.000 140.000
2021-02-12 2021-02-10 4 Koneru Mythili MRKR Employee Stock Option (right to buy) A - Award D 3,29 140.000 140.000
2021-02-12 2021-02-10 4 Kim Anthony H. MRKR Employee Stock Option (right to buy) A - Award D 3,29 160.000 160.000
2021-02-12 2021-02-10 4 Hoang Tsvetelina P MRKR Employee Stock Option (right to buy) A - Award D 3,29 40.000 40.000
2021-02-12 2021-02-11 4 Hoang Peter L. MRKR Employee Stock Option (right to buy) A - Award D 3,06 430.000 430.000
2021-02-12 2021-02-10 4 Garrett Gerald MRKR Employee Stock Option (right to buy) A - Award D 3,29 40.000 40.000
2021-02-12 2021-02-10 4 Agopyan Nadia MRKR Employee Stock Option (right to buy) A - Award D 3,29 40.000 40.000
2020-06-19 2020-06-16 4 Eastern Capital LTD MRKR Series E-1 Warrant J - Other D 15,00 -416.667 0
2020-03-12 2020-03-10 4 Loiacono Michael MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 119.100 119.100
2020-03-12 2020-03-10 4 Loiacono Michael MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 20.900 20.900
2020-03-12 2020-03-10 4 Szymanska Anna MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 32.500 32.500
2020-03-12 2020-03-10 4 Szymanska Anna MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 7.500 7.500
2020-03-12 2020-03-10 4 Vera Juan MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 113.400 113.400
2020-03-12 2020-03-10 4 Vera Juan MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 26.600 26.600
2020-03-12 2020-03-10 4 Hoang Peter L. MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 388.800 388.800
2020-03-12 2020-03-10 4 Hoang Peter L. MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 41.200 41.200
2020-03-12 2020-03-10 4 Agopyan Nadia MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 32.700 32.700
2020-03-12 2020-03-10 4 Agopyan Nadia MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 7.300 7.300
2020-03-12 2020-03-10 4 Garrett Gerald MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 38.300 38.300
2020-03-12 2020-03-10 4 Garrett Gerald MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 1.700 1.700
2020-03-12 2020-03-10 4 Hoang Tsvetelina P MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 25.400 25.400
2020-03-12 2020-03-10 4 Hoang Tsvetelina P MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 14.600 14.600
2020-03-12 2020-03-10 4 Kim Anthony H. MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 127.500 127.500
2020-03-12 2020-03-10 4 Kim Anthony H. MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 32.500 32.500
2020-03-12 2020-03-10 4 Koneru Mythili MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 116.100 116.100
2020-03-12 2020-03-10 4 Koneru Mythili MRKR Employee Stock Option (Right to Buy) A - Award D 2,12 23.900 23.900
2020-02-20 2020-02-18 4 Eastern Capital LTD MRKR Series A-1 Warrant X - Other D 1,20 -416.667 0
2020-02-20 2020-02-18 4 Eastern Capital LTD MRKR Common Stock X - Other D 1,2000 416.667 500 4.050.001
2019-08-19 2019-08-15 4 Agopyan Nadia MRKR Employee Stock Option (right to buy) A - Award D 4,80 200.000 200.000
2019-08-15 2019-08-14 4 Hoang Peter L. MRKR Common Stock P - Purchase D 4,6200 10.000 46 189.711
2019-08-08 3 ELMS STEVE MRKR Common Stock I 4.000.000
2019-08-08 3 ELMS STEVE MRKR Common Stock I 4.000.000
2019-08-08 3 ELMS STEVE MRKR Common Stock I 4.000.000
2019-08-08 2019-08-06 4 ELMS STEVE MRKR Stock Option (right to buy) A - Award D 4,21 12.500 12.500
2019-05-13 2019-05-09 4 Wasserman Frederick Gerald MRKR Common Stock A - Award D 7.260 25.543
2019-05-13 2019-05-09 4 Laskow-Pooley David MRKR Common Stock A - Award D 7.260 25.543
2019-05-13 2019-05-09 4 Wilson John Robert MRKR Common Stock A - Award D 7.260 6.068.043
2019-05-13 2019-05-09 4 Eansor Norman David MRKR Common Stock A - Award D 7.260 7.260
2018-12-28 3 Leen Ann M. MRKR Common Stock D 3.986.118
2018-12-28 3 Leen Ann M. MRKR Common Stock D 3.986.118
2018-12-28 3 Leen Ann M. MRKR Common Stock D 3.986.118
2018-12-28 3 Hoang Tsvetelina P By Husband MRKR Common Stock I 359.422
2018-12-28 3 Hoang Tsvetelina P By Husband MRKR Common Stock I 359.422
2018-12-28 3 Hoang Tsvetelina P By Husband MRKR Common Stock I 359.422
2018-11-29 2018-11-27 4 Kim Anthony H. MRKR Employee Stock Option (Right to Buy) A - Award D 6,81 400.000 400.000
2018-10-23 2018-10-19 4 Loiacono Michael MRKR Employee Stock Option (Right to Buy) A - Award D 9,18 300.000 300.000
2018-10-23 2018-10-19 4 Vera Juan MRKR Employee Stock Option (Right to Buy) A - Award D 9,18 500.000 500.000
2018-10-23 2018-10-19 4 Hoang Peter L. By Wife MRKR Employee Stock Option (Right to Buy) A - Award I 9,18 200.000 200.000
2018-10-23 2018-10-19 4 Hoang Peter L. MRKR Employee Stock Option (Right to Buy) A - Award D 9,18 1.359.855 1.359.855
2018-10-19 2018-10-17 4 Eansor Norman David MRKR Non-Employee Director Stock Option (Right to Buy) A - Award D 8,34 12.500 12.500
2018-10-19 2018-10-17 4 Wilson John Robert MRKR Non-Employee Director Stock Option (Right to Buy) A - Award D 8,34 12.500 12.500
2018-10-19 3 Wilson John Robert MRKR Common Stock D 12.121.566
2018-10-19 3 Wilson John Robert MRKR Common Stock D 12.121.566
2018-10-19 3 Wilson John Robert MRKR Common Stock D 12.121.566
2018-10-19 3 Vera Juan MRKR Common Stock D 3.986.118
2018-10-19 3 Vera Juan MRKR Common Stock D 3.986.118
2018-10-19 3 Vera Juan MRKR Common Stock D 3.986.118
2018-10-18 3 NEA 16 GP, LLC MRKR Common Stock D 10.000.000
2018-10-18 3 NEA 16 GP, LLC MRKR Common Stock D 10.000.000
2018-10-18 3 NEA 16 GP, LLC MRKR Common Stock D 10.000.000
2018-10-18 3 NEA 16 GP, LLC MRKR Common Stock D 10.000.000
2018-10-18 3 NEA 16 GP, LLC MRKR Common Stock D 10.000.000
2018-10-18 3 BARRIS PETER J See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 BARRIS PETER J See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 BARRIS PETER J See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 BASKETT FOREST See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 BASKETT FOREST See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 BASKETT FOREST See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Behbahani Ali See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Behbahani Ali See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Behbahani Ali See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Chang Carmen See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Chang Carmen See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Chang Carmen See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Florence Anthony A. Jr. See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Florence Anthony A. Jr. See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Florence Anthony A. Jr. See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Makhzoumi Mohamad See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Makhzoumi Mohamad See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Makhzoumi Mohamad See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 MAKOWER JOSHUA See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 MAKOWER JOSHUA See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 MAKOWER JOSHUA See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 MOTT DAVID M See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 MOTT DAVID M See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 MOTT DAVID M See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 SANDELL SCOTT D See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 SANDELL SCOTT D See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 SANDELL SCOTT D See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Sonsini Peter W. See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Sonsini Peter W. See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Sonsini Peter W. See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Viswanathan Ravi See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Viswanathan Ravi See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Viswanathan Ravi See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Walker Paul Edward See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Walker Paul Edward See Note 1 MRKR Common Stock I 10.000.000
2018-10-18 3 Walker Paul Edward See Note 1 MRKR Common Stock I 10.000.000
2018-10-17 2018-10-16 4 Wasserman Frederick Gerald TPIV Common Stock A - Award D 5.168 18.283
2018-10-17 2018-10-16 4 Laskow-Pooley David TPIV Common Stock A - Award D 5.168 18.283
2018-10-17 2018-10-16 4 Reddish Mark TPIV Common Stock A - Award D 4.106 36.110
2018-10-17 2018-10-16 4 Grisewood Sherry TPIV Common Stock A - Award D 4.106 19.582
2018-10-17 2018-10-16 4 Silverman Joshua TPIV Common Stock A - Award D 4.106 17.221
2018-10-10 2018-10-09 4 WILSON GLYNN TPIV Employee Employment Agreement (right to receive) M - Exercise D -31.120 0
2018-10-10 2018-10-09 4 WILSON GLYNN TPIV Common Stock F - Taxes D -7.561 181.776
2018-10-10 2018-10-09 4 WILSON GLYNN TPIV Common Stock A - Award D 31.120 189.337
2018-09-25 2018-09-22 4 WILSON GLYNN TPIV Common Stock A - Award D 31.120 31.120
2018-05-16 2018-05-14 4 Eastern Capital LTD TPIV Common Stock P - Purchase D 2,4000 1.300.000 3.120 5.300.002
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Series F Warrants J - Other I 7,20 49.167 49.167
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Series E-1 Warrants J - Other I 15,00 31.093 31.093
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Series E Warrants J - Other I 4,50 10.574 10.574
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Series D Warrants J - Other I 9,00 41.667 41.667
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Series A Warrants J - Other I 1,20 41.667 41.667
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Series C Warrants J - Other I 6,00 44.000 44.000
2018-03-02 2018-02-28 4 Silverman Joshua By JNS Holdings Group LLC TPIV Common Stock J - Other I 153.333 153.333
2017-09-26 2017-09-22 4 WILSON GLYNN TPIV Common Stock F - Taxes D 3,1800 -27.350 -87 158.217
2017-09-26 2017-09-22 4 WILSON GLYNN TPIV Common Stock A - Award D 3,1800 100.000 318 185.567
2017-09-25 2017-09-22 4 Hoang Peter L. TPIV Common Stock F - Taxes D 3,1800 -70.289 -224 179.711
2017-09-25 2017-09-22 4 Hoang Peter L. TPIV Common Stock A - Award D 3,1800 250.000 795 250.000
2017-08-30 2017-08-29 4 Wasserman Frederick Gerald TPIV Common Stock A - Award D 13.115 13.115
2017-08-30 2017-08-29 4 Silverman Joshua TPIV Common Stock A - Award D 13.115 13.115
2017-08-30 2017-08-29 4 Reddish Mark TPIV Common Stock A - Award D 13.115 32.004
2017-08-30 2017-08-29 4 Grisewood Sherry TPIV Common Stock A - Award D 13.115 15.476
2017-08-30 2017-08-29 4 Laskow-Pooley David TPIV Common Stock A - Award D 13.115 13.115
2017-03-13 2017-03-09 4 WILSON GLYNN TPIV Common Stock A - Award D 12.761 85.567
2017-03-13 2017-03-09 4 BONFIGLIO JOHN N TPIV Common Stock A - Award D 5.220 26.054
2016-12-14 2016-12-12 4 BONFIGLIO JOHN N TPIV Employee Stock Option (Right to Buy) M - Exercise D 1,74 -10.417 85.416
2016-12-14 2016-12-12 4 BONFIGLIO JOHN N By Spouse TPIV Common Stock G - Gift I 10.417 10.417
2016-12-14 2016-12-12 4 BONFIGLIO JOHN N TPIV Common Stock G - Gift D -10.417 20.834
2016-12-14 2016-12-12 4 BONFIGLIO JOHN N TPIV Common Stock M - Exercise D 1,7400 10.417 18 31.251
2016-11-30 2016-11-28 4 Silverman Joshua TPIV Employee Stock Option (Right to Buy) A - Award D 4,82 12.500 12.500
2016-08-25 2016-08-25 4 Loiacono Michael TPIV Employee Stock Option (Right to Buy) A - Award D 0,48 650.000 650.000
2016-08-12 2016-08-10 4 Eastern Capital LTD TPIV Series F-1 Warrant J - Other D 0,60 5.000.000 1
2016-08-12 2016-08-10 4 Eastern Capital LTD TPIV Series C-1 Warrant X - Other D 0,50 -5.000.000 0
2016-08-12 2016-08-10 4 Eastern Capital LTD TPIV Common Stock J - Other D 3.000.000 28.000.000
2016-08-12 2016-08-10 4 Eastern Capital LTD TPIV Common Stock X - Other D 0,5000 5.000.000 2.500 25.000.000
2016-07-19 2016-07-18 4 BONFIGLIO JOHN N TPIV Employee Stock Option (Right to Buy) A - Award D 0,48 750.000 1.150.000
2016-07-19 2016-07-15 4 BONFIGLIO JOHN N TPIV Common Stock A - Award D 250.000 250.000
2016-01-28 2016-01-26 4 Wasserman Frederick Gerald TPIV Employee Stock Option (Right to Buy) A - Award D 0,63 150.000 150.000
2015-11-16 2015-11-12 4 Grisewood Sherry TPIV Employee Stock Option (Right to Buy) A - Award D 0,60 150.000 150.000
2015-11-16 2015-11-12 4 Reddish Mark TPIV Employee Stock Option (Right to Buy) A - Award D 0,60 150.000 154.500
2015-11-16 2015-11-12 4 WILSON GLYNN TPIV Employee Stock Option (Right to Buy) A - Award D 0,60 2.000.000 2.038.000
2015-11-16 2015-11-12 4 WILSON GLYNN TPIV Common Stock F - Taxes D 0,6050 86.782 53 873.675
2015-11-16 2015-11-12 4 WILSON GLYNN TPIV Common Stock A - Award D 0,6050 315.000 191 960.457
2015-11-13 3 Grisewood Sherry TPIV Common Stock D 410
2015-11-13 3 Grisewood Sherry TPIV Common Stock D 410
2015-11-13 2014-02-26 4 Grisewood Sherry TPIV Common Stock J - Other D 0,8000 28.125 22 28.330
2015-11-13 2014-02-26 4 Reddish Mark TPIV Common Stock J - Other D 0,8000 225.000 180 226.667
2015-11-13 2012-04-30 4 Reddish Mark TPIV Employee Stock Option (Right to Buy) A - Award D 17,00 2.500 4.500
2015-11-13 2011-02-16 4 Reddish Mark TPIV Employee Stock Option (Right to Buy) A - Award D 17,00 2.000 2.000
2015-11-13 2014-12-02 4 WILSON GLYNN TPIV Common Stock A - Award D 1,0000 120.000 120 645.457
2015-11-13 2014-02-26 4 WILSON GLYNN TPIV Common Stock J - Other D 0,8000 513.319 411 525.457
2015-11-13 2011-02-16 4 WILSON GLYNN TPIV Employee Stock Option (Right to Buy A - Award D 17,00 1.600 38.000
2015-11-13 2015-03-19 4 Laskow-Pooley David TPIV Employee Stock Option (Right to Buy) A - Award D 0,21 150.000 150.000
2015-11-09 2015-07-23 4 BONFIGLIO JOHN N TPIV Employee Stock Option (Right to Buy) A - Award D 0,57 150.000 400.000
2015-09-11 2015-09-09 4 Eastern Capital LTD TPIV Series B-1 Warrant X - Other D 0,20 -10.000.000 0
2015-09-11 2015-09-09 4 Eastern Capital LTD TPIV Common Stock X - Other D 0,2000 10.000.000 2.000 20.000.000
2015-06-18 2015-06-16 4 Eastern Capital LTD TPIV Series C-1 Warrant X - Other D 0,50 -5.000.000 1
2015-06-18 2015-06-16 4 Eastern Capital LTD TPIV Common Stock X - Other D 0,5000 5.000.000 2.500 10.000.000
2015-06-01 2015-05-28 4 Eastern Capital LTD TPIV Series B-1 Warrant J - Other D 0,20 10.000.000 1
2015-06-01 2015-05-28 4 Eastern Capital LTD TPIV Series C-1 Warrant J - Other D 0,50 10.000.000 1
2015-06-01 2015-05-28 4 Eastern Capital LTD TPIV Series A-1 Warrant J - Other D 1,50 -5.000.000 0
2015-06-01 2015-05-28 4 Eastern Capital LTD TPIV Series C-1 Warrant J - Other D 1,00 -5.000.000 0
2015-06-01 2015-05-28 4 Eastern Capital LTD TPIV Series B-1 Warrant J - Other D 0,40 -5.000.000 0
2015-06-01 2015-05-28 4 Eastern Capital LTD TPIV Series A-1 Warrant J - Other D 0,10 5.000.000 1
2015-03-17 3 DART KENNETH BRYAN TPIV Common Stock D 10.000.000
2015-03-17 3 DART KENNETH BRYAN TPIV Common Stock D 10.000.000
2015-03-17 3 DART KENNETH BRYAN TPIV Common Stock D 10.000.000
2015-03-17 3 DART KENNETH BRYAN TPIV Common Stock D 10.000.000
2012-04-24 2012-02-17 4 WILSON GLYNN TPIV Common Stock J - Other D 0,1500 166.667 25 1.213.726
2012-04-20 2012-02-17 4 CORIN DENIS TPIV Common Stock J - Other D 0,1500 166.667 25 2.394.535
2012-04-20 3 Reddish Mark TPIV Common Stock D 166.667
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Other Listings
DE:GX1 1,06 €
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista